VERA — Vera Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- $2.07bn
- $1.96bn
- 41
- 15
- 82
- 43
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 3.19 | 53.7 | 79.7 | 115 | 161 |
Net Total Receivables | 0 | 0.052 | — | — | — |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 3.56 | 54.3 | 82.5 | 126 | 172 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.39 | 0 | — | 5.22 | 3.04 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 5.38 | 54.6 | 83.7 | 131 | 176 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.06 | 2.41 | 7.69 | 25.6 | 22.3 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 1.83 | 4.33 | 14.2 | 54.5 | 73.9 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 3.55 | 50.2 | 69.6 | 76.9 | 102 |
Total Liabilities & Shareholders' Equity | 5.38 | 54.6 | 83.7 | 131 | 176 |
Total Common Shares Outstanding |